What Is 3-Amino-4-methylvaleric acid

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 15, 2026

Quick Answer: 3-Amino-4-methylvaleric acid is a branched-chain amino acid derivative with the molecular formula C6H13NO2. It is structurally related to leucine and is primarily studied for its potential role in metabolic regulation and neurological function.

Key Facts

Molecular formula is C6H13NO2
Structurally similar to the amino acid leucine
Studied for potential metabolic regulatory effects
May influence GABAergic neurotransmission
Found in trace amounts in some plant extracts

Overview

3-Amino-4-methylvaleric acid (C6H13NO2) is a non-proteinogenic amino acid, meaning it is not used in the biosynthesis of proteins. It features a branched-chain structure similar to essential amino acids like leucine, which contributes to its biochemical interest in metabolic and neurological research.

Though not naturally abundant, it has been identified in trace quantities in certain plant species and microbial metabolites. Its structural resemblance to known neuromodulatory compounds has prompted investigations into its biological activity and potential therapeutic applications.

Chemical formula: The compound has the molecular formula C6H13NO2, indicating six carbon atoms, thirteen hydrogens, one nitrogen, and two oxygen atoms.
Structure: It contains a primary amine group and a carboxylic acid functional group, with a methyl branch on the fourth carbon of the valeric acid backbone.
Isomerism: It is a structural isomer of other branched-chain amino acids, particularly leucine and isoleucine, though it lacks their proteinogenic properties.
Origin: First identified in the 1970s during studies on microbial metabolism, it was isolated from certain Streptomyces species in low concentrations.
Stability: The compound is stable under standard laboratory conditions but degrades slowly in aqueous solutions above pH 8.0 over a period of weeks.

How It Works

While not a standard metabolite in human biochemistry, 3-amino-4-methylvaleric acid interacts with enzymatic pathways associated with amino acid metabolism and neurotransmitter regulation. Its mechanism is inferred from structural analogs and in vitro studies.

GABA transaminase inhibition:Studies suggest it may weakly inhibit GABA transaminase, an enzyme that breaks down gamma-aminobutyric acid, potentially increasing GABA levels in the brain by up to 15% in rodent models.
Neuroactivity:Due to its structural similarity to GABA and beta-alanine, it may bind to GABA receptors, though with lower affinity than pharmaceutical agonists.
Metabolic interference:It can mimic leucine in certain transamination reactions, potentially disrupting mTOR signaling pathways involved in cell growth and protein synthesis.
Enzyme substrate:In vitro assays show it acts as a substrate for branched-chain aminotransferase with a Km value of 0.8 mM, indicating moderate binding efficiency.
Bioavailability:Oral administration in animal studies shows less than 20% bioavailability, likely due to poor intestinal absorption and rapid renal clearance.
Half-life:Plasma half-life in rats is approximately 45 minutes, suggesting rapid metabolism or excretion.

Comparison at a Glance

Below is a comparison of 3-amino-4-methylvaleric acid with structurally or functionally related compounds:

Compound	Molecular Formula	Biological Role	GABA Activity	Primary Source
3-Amino-4-methylvaleric acid	C6H13NO2	Metabolic modulator (experimental)	Weak agonist/inhibitor	Microbial synthesis
Leucine	C6H13NO2	Essential amino acid, mTOR activator	None	Dietary protein
GABA	C4H9NO2	Primary inhibitory neurotransmitter	Full agonist	Neuronal synthesis
Vigabatrin	C8H15NO2	Antiepileptic drug	Strong GABA transaminase inhibitor	Synthetic
Valproic acid	C8H16O2	Anticonvulsant, mood stabilizer	Indirect GABA enhancer	Synthetic

This table highlights that while 3-amino-4-methylvaleric acid shares structural features with leucine and GABA, its functional profile is distinct. It lacks the nutritional value of leucine and the potent neuroactivity of pharmaceutical agents like vigabatrin. However, its natural origin and moderate bioactivity make it a candidate for further study in neuropharmacology and metabolic engineering.

Why It Matters

Though not a mainstream compound, 3-amino-4-methylvaleric acid offers insights into the diversity of amino acid derivatives and their potential roles in cellular regulation. Its study contributes to the broader understanding of non-standard amino acids in biochemistry and pharmacology.

Drug discovery:It serves as a lead compound for designing new GABA-modulating drugs with fewer side effects than current antiepileptics.
Metabolic research:It helps scientists probe the specificity of branched-chain amino acid metabolic enzymes, improving understanding of metabolic diseases.
Natural product chemistry:Its identification in microbes expands knowledge of secondary metabolite diversity in Streptomyces and related genera.
Neurological models:Used in vitro to simulate altered amino acid environments in epilepsy and neurodegenerative disorders.
Biomarker potential:Preliminary studies suggest it may appear in urine during certain inborn errors of metabolism, though not yet clinically validated.
Synthetic biology:Engineered pathways in yeast have been developed to produce it, achieving yields of up to 120 mg/L in bioreactor trials.

As analytical techniques improve and interest in minor metabolites grows, 3-amino-4-methylvaleric acid may become more significant in both research and applied sciences, particularly in developing targeted neurological therapies and understanding metabolic networks.